
---
title: '中泰证券：新冠口服药有望成为今年重要投资机会'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=211'
author: 证券时报网
comments: false
date: Sun, 20 Mar 2022 21:54:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=211'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600918" style="color: #2f67d1;text-decoration: none;" code="600918" target="_blank">中泰证券</a>研报指出，在全球疫情反复、放开需求背景下，新冠口服药凭借疗效及便捷等优势，有望成为抗疫重要手段。考虑目前全球产能的短缺以及原研对研发进度的要求，国内医药制造企业有望通过多年积累的工艺开发、规模生产、客户关系等优势，深度参与产业链各环节，带来一定业绩弹性。我们认为，新冠口服药有望成为今年重要投资机会，建议积极把握，重点关注进度靠前的国内研发创新企业、海外大药企创新药CDMO产业链以及仿制药产业链，如<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688180" style="color: #2f67d1;text-decoration: none;" code="688180" target="_blank">君实生物</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" style="color: #2f67d1;text-decoration: none;" code="603259" target="_blank">药明康德</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" style="color: #2f67d1;text-decoration: none;" code="002821" target="_blank">凯莱英</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300363" style="color: #2f67d1;text-decoration: none;" code="300363" target="_blank">博腾股份</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ000739" style="color: #2f67d1;text-decoration: none;" code="000739" target="_blank">普洛药业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603456" style="color: #2f67d1;text-decoration: none;" code="603456" target="_blank">九洲药业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300702" style="color: #2f67d1;text-decoration: none;" code="300702" target="_blank">天宇股份</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603229" style="color: #2f67d1;text-decoration: none;" code="603229" target="_blank">奥翔药业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603520" style="color: #2f67d1;text-decoration: none;" code="603520" target="_blank">司太立</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS605116" style="color: #2f67d1;text-decoration: none;" code="605116" target="_blank">奥锐特</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300636" style="color: #2f67d1;text-decoration: none;" code="300636" target="_blank">同和药业</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603538" style="color: #2f67d1;text-decoration: none;" code="603538" target="_blank">美诺华</a>等。</p>

                  
</div>
            